JohnWarrenMcBroomMD

Oncology • York, PA

Gynecologic Cancer

Physician

Join to view full profile

Dr. McBroom is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McBroom's full profile

Already have an account?

Office
25 Monument Rd
Ste 295
York, PA 17403
Phone+1 717-851-6120

Fax+1 717-409-6223

Education & Training

Tripler Army Medical CenterResidency, Obstetrics and Gynecology, 1993 - 1997
Medical College of Georgia at Augusta UniversityClass of 1993
National Capital ConsortiumFellowship, Gynecologic Oncology

Certifications & Licensure

AL State Medical License 2024 - 2025
GA State Medical License 1998 - 2025
MD State Medical License 2021 - 2025
MT State Medical License 2018 - 2025
DC State Medical License 2021 - 2024
PA State Medical License 2017 - 2024
FL State Medical License 2006 - 2023
NY State Medical License 2021 - 2023
HI State Medical License 1995 - 2016
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Join now to see all

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FACS) American College of Surgeons

Clinical Trials

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Start of enrollment: 2017 Jan 30
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

37 citations
Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian...
Kathleen M. Darcy, William E. Brady, John W. McBroom, Jeffrey G. Bell, Robert C. Young
Gynecologic Oncology. 2008-12-01
31 citations
Erythropoeitin receptor function and expression in epithelial ovarian carcinoma
John W. McBroom, Geza Acs, G. Scott Rose, Thomas C. Krivak, Ahmed Mohyeldin
Gynecologic Oncology. 2005-12-01
16 citations
Novel techniques to improve split-thickness skin graft viability during vulvo-vaginal reconstruction
Louis A. Dainty, Jason J. Bosco, John W. McBroom, William E. Winter, G. Scott Rose
Gynecologic Oncology. 2005-06-01

Professional Memberships

American College of Surgeons - ACS
Member